Top 10 Ciprofloxacin (Cipro) Generic Manufacturers in India

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:
The pharmaceutical industry in India has been booming, with a growing focus on generic drug manufacturing. Ciprofloxacin, commonly known as Cipro, is a widely used antibiotic medication that has seen a high demand in both domestic and international markets. In recent years, India has emerged as a key player in the production of generic Cipro, with several manufacturers leading the way in terms of production volume and market share.

Top 10 Ciprofloxacin (Cipro) Generic Manufacturers in India:

1. Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. is one of the largest pharmaceutical companies in India, known for its high-quality generic medications. With a production volume of over 1,000 tons of Ciprofloxacin annually, Sun Pharma holds a significant market share in the generic Cipro industry.

2. Cipla Ltd.
Cipla Ltd. is another major player in the Indian pharmaceutical industry, with a strong presence in the generic drug market. Cipla produces over 800 tons of Ciprofloxacin each year and is known for its competitive pricing and quality products.

3. Lupin Limited
Lupin Limited is a leading pharmaceutical company in India, specializing in the production of generic drugs. Lupin’s Ciprofloxacin production volume exceeds 700 tons annually, making it a key player in the generic Cipro market.

4. Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. is a well-known name in the Indian pharmaceutical industry, with a focus on research and development of generic medications. With over 600 tons of Ciprofloxacin produced yearly, Dr. Reddy’s is a trusted manufacturer of generic Cipro.

5. Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. is a fast-growing pharmaceutical company in India, known for its wide range of generic drug offerings. Aurobindo Pharma produces over 500 tons of Ciprofloxacin annually, catering to both domestic and international markets.

6. Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd. has a strong presence in the Indian pharmaceutical market, with a focus on quality and innovation. With a production volume of over 400 tons of Ciprofloxacin per year, Torrent Pharmaceuticals is a key player in the generic Cipro industry.

7. Zydus Cadila
Zydus Cadila is a leading pharmaceutical company in India, known for its research and development capabilities. Zydus Cadila produces over 300 tons of Ciprofloxacin annually, offering a wide range of generic Cipro products to meet market demand.

8. Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd. is a growing player in the Indian pharmaceutical industry, with a focus on quality and affordability. With a production volume of over 200 tons of Ciprofloxacin each year, Intas Pharmaceuticals is gaining traction in the generic Cipro market.

9. Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd. is a well-established name in the Indian pharmaceutical industry, with a strong focus on research and development. Glenmark produces over 150 tons of Ciprofloxacin annually, offering high-quality generic Cipro products to consumers.

10. Alkem Laboratories Ltd.
Alkem Laboratories Ltd. is a trusted pharmaceutical company in India, known for its commitment to quality and innovation. With a production volume of over 100 tons of Ciprofloxacin per year, Alkem Laboratories is a key player in the generic Cipro market.

Insights:
The Indian pharmaceutical industry continues to grow rapidly, with a focus on generic drug manufacturing. The top 10 Ciprofloxacin generic manufacturers in India are leading the way in meeting the demand for high-quality and affordable medications. With increasing investments in research and development, these companies are expected to further expand their market share and production volumes in the coming years. In 2020, the Indian generic drug market was valued at over $20 billion, with Ciprofloxacin being one of the key contributors to this growth. As the global demand for generic medications continues to rise, India is positioned to remain a key player in the pharmaceutical industry.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →